The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.
 
Peter Borchmann
Honoraria - BMS GmbH & Co. KG; Incyte; MSD/Merck; Roche; Takeda/Millennium
Consulting or Advisory Role - BMS GmbH & Co. KG; Miltenyi Biotec; MSD/Merck; Roche; Takeda/Millennium
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Novartis (Inst); Takeda/Millennium (Inst)
 
Alden A Moccia
Consulting or Advisory Role - Janssen; Roche; Takeda
 
Richard Greil
Stock and Other Ownership Interests - Lilly (Inst); Novo Nordisk (Inst)
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Abbvie; Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Gundolf Schneider
No Relationships to Disclose
 
Mark Hertzberg
Honoraria - Janssen; Roche
Consulting or Advisory Role - BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Valdete Schaub
No Relationships to Disclose
 
Andreas Huettmann
No Relationships to Disclose
 
Felix Keil
No Relationships to Disclose
 
Judith Dierlamm
No Relationships to Disclose
 
Mathias Haenel
Honoraria - BMS GmbH & Co. KG; Falk Foundation; Gilead Sciences; Novartis; Novartis; SOBI; SOBI
Consulting or Advisory Role - Amgen; Amgen; Gilead Sciences; Incyte; Janssen; Janssen; Kite/Gilead; Novartis; Pfizer; Roche Pharma AG; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; SOBI
Travel, Accommodations, Expenses - Abbvie
 
Julia Meissner
No Relationships to Disclose
 
Stephan Mathas
No Relationships to Disclose
 
Josee M Zijlstra
No Relationships to Disclose
 
Alexander Fosså
Honoraria - Abbvie; BMS Norway; Gilead Sciences; Takeda
 
Justin Ferdinandus
Honoraria - Roche; Takeda/Millennium
Consulting or Advisory Role - Takeda/Millennium
 
Michael Fuchs
Honoraria - Celgene/Bristol-Myers Squibb; Janssen; Takeda
 
Wolfram Klapper
Honoraria - Amgen; EUSA Pharma (Inst); Incyte (Inst); Roche (Inst); Roche (Inst); Roche/Genentech (Inst); Takeda
Research Funding - Amgen (Inst); Bayer (Inst); Bayer (Inst); Regeneron (Inst); Regeneron (Inst); Roche (Inst); Roche (Inst); Takeda (Inst)
 
Hans-Theodor Eich
No Relationships to Disclose
 
Carsten Kobe
No Relationships to Disclose
 
Volker Diehl
No Relationships to Disclose